5 Hot Biotechs to Hold Over The WeekendMy Post-FDA Over-The-Weekend Watchlist:
$GLYC
$ONCT
$ONCY
$PIRS
$AGEN
All of these biotechs have phase one cancer treatment clinical-trial data releases this weekend. Based on my research, these are the ones that I think are most likely to release good data. Since they are all in phase one, it is